Sienna Biopharmaceuticals Hires Chief Commercial Officer

Sienna Biopharmaceuticals Inc., an aesthetic dermatological product company based in Westlake Village, has hired Allergan Inc. senior marketing manager Caroline Van Hove as its chief commercial officer. “Caroline brings … an exemplary track record of establishing winning commercial strategies, building highly effective teams and leading international commercial operations for billion-dollar brands,” Sienna Chief Executive Dr. Frederick Beddingfield III said in a statement. Van Hove’s 20-year career includes roles in the pharmaceutical, consumer and medical device industries, according Sienna. At Allergan – the maker of Botox, with market cap of $53 billion – she managed the company’s commercial operations in Europe, Asia and the Middle East. Van Hove will oversee the build-out of Sienna’s commercial strategy and operations. Sienna currently has five products in the clinical stages of development, including treatments for acne and psoriasis. Sienna stock (SNNA) fell 72 cents a share, or about 3.7 percent, on Friday to close at $18.53 on the Nasdaq. The Nasdaq overall fell 2.4 percent.